文献速递真菌感染

法国2012-2018年黄曲霉所致侵袭性曲霉病特征

Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018.
PubMed 文献 · Emerg Infect Dis · 2025-01-01

该研究回顾性分析法国2012-2018年报告的54例黄曲霉所致侵袭性曲霉病病例,发现基础风险因素以恶性肿瘤、实体器官移植和糖尿病为主,感染多局限化,肺胸膜和耳鼻喉为常见部位,真菌合并感染在肺部感染中常见,30天和90天全因病死率分别为39.2%和47.1%,且随风险因素、感染部位和真菌合并感染而变化。

要点

  • 87%(47/54)感染为局限型,其中肺胸膜33例、耳鼻喉13例。
  • 肺部局限感染主要风险因素为恶性肿瘤(70%,23/33)和实体器官移植(21%,7/33)。
  • 糖尿病与耳鼻喉局限感染相关(61.5%,8/13),肺部真菌合并感染常见(36%,12/33)。

核心结论

  • 黄曲霉所致侵袭性曲霉病多表现为局限型感染,肺胸膜和耳鼻喉为常见部位,病死率较高,临床医生应保持警惕并将其纳入侵袭性曲霉病的鉴别诊断。

研究设计与样本

  • 回顾性分析法国2012-2018年报告的54例黄曲霉所致侵袭性曲霉病病例。

主要发现

  • 87%(47/54)感染为局限型,其中肺胸膜33例、耳鼻喉13例。
  • 肺部局限感染中恶性肿瘤占70%(23/33)、实体器官移植占21%(7/33);糖尿病与耳鼻喉局限感染相关(61.5%,8/13)。
  • 肺部感染真菌合并感染常见(36%,12/33),耳鼻喉感染无合并感染(0例)。
  • 抗真菌单药治疗45/50(90%),主要为伏立康唑(67%,30/45)。
  • 30天全因病死率39.2%,90天47.1%,病死率随风险因素、感染部位和真菌合并感染而变化。

关键数值与推荐

  • 87%(47/54)感染为局限型,其中肺胸膜33例、耳鼻喉13例。
  • 肺部局限感染中恶性肿瘤70%(23/33)、实体器官移植21%(7/33);糖尿病与耳鼻喉局限感染相关61.5%(8/13)。
  • 肺部真菌合并感染36%(12/33),耳鼻喉感染0例。
  • 抗真菌单药治疗45/50(90%),伏立康唑67%(30/45)。
  • 30天全因病死率39.2%,90天47.1%。

临床怎么用

  • 临床医生应保持对黄曲霉的警惕,并将其纳入侵袭性曲霉病的鉴别诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive aspergillosis (IA) caused by Aspergillus flavus remains poorly described. We retrospectively analyzed 54 cases of IA caused by A. flavus reported in France during 2012-2018. Among cases, underlying IA risk factors were malignancy, solid organ transplantation, and diabetes. Most (87%, 47/54) infections were localized, of which 33 were pleuropulmonary and 13 were ear-nose-throat (ENT) infection sites. Malignancy (70% [23/33]) and solid organ transplantation (21% [7/33]) were the main risk factors in localized pulmonary infections, and diabetes mellitus was associated with localized ENT involvement (61.5%, [8/13]). Fungal co-infections were frequent in pulmonary (36%, 12/33) but not ENT IA (0 cases). Antifungal monotherapy was prescribed in 45/50 (90%) cases, mainly voriconazole (67%, 30/45). All-cause 30-day case-fatality rates were 39.2% and 90-day rates were 47.1%, and rates varied according to risk factor, IA site, and fungal co-infections. Clinicians should remain vigilant for A. flavus and consider it in the differential diagnosis for IA.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bertin-Biasutto L, Paccoud O, Garcia-Hermoso D, et al. Features of Invasive Aspergillosis Caused by Aspergillus flavus, France, 2012-2018. Emerg Infect Dis. 2025. PMID: 40305205. doi:10.3201/eid3105.241392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。